Patents by Inventor Russell W. Pelham

Russell W. Pelham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230263733
    Abstract: Disclosed herein are solid oral dosage formulations comprising sodium sulfate, magnesium sulfate, and potassium chloride for inducing purgation of the colon of a subject. Furthermore, the disclosed compositions and formulations are useful to cleanse the colon when administered in sufficient quantities. Methods for inducing purgation of the colon and for cleansing the colon are also disclosed.
    Type: Application
    Filed: May 1, 2023
    Publication date: August 24, 2023
    Applicant: Braintree Laboratories, Inc.
    Inventors: Mark Cleveland, Edmund V. Dennett, JR., Russell W. Pelham
  • Publication number: 20230256010
    Abstract: Disclosed herein are solid oral dosage formulations comprising sodium sulfate, magnesium sulfate, and potassium chloride for inducing purgation of the colon of a subject. Furthermore, the disclosed compositions and formulations are useful to cleanse the colon when administered in sufficient quantities. Methods for inducing purgation of the colon and for cleansing the colon are also disclosed.
    Type: Application
    Filed: April 26, 2023
    Publication date: August 17, 2023
    Applicant: Braintree Laboratories, Inc.
    Inventors: Mark vB Cleveland, Edmund V. Dennett, JR., Russell W. Pelham
  • Patent number: 11638697
    Abstract: Disclosed herein are solid oral dosage formulations comprising sodium sulfate, magnesium sulfate, and potassium chloride for inducing purgation of the colon of a subject. Furthermore, the disclosed compositions and formulations are useful to cleanse the colon when administered in sufficient quantities. Methods for inducing purgation of the colon and for cleansing the colon are also disclosed.
    Type: Grant
    Filed: June 7, 2021
    Date of Patent: May 2, 2023
    Assignee: Braintree Laboratories, Inc.
    Inventors: Mark vB Cleveland, Edmund V. Dennett, Jr., Russell W Pelham
  • Patent number: 11382864
    Abstract: Disclosed herein are solid oral dosage formulations comprising sodium sulfate, magnesium sulfate, and potassium chloride for inducing purgation of the colon of a subject. Furthermore, the disclosed compositions and formulations are useful to cleanse the colon when administered in sufficient quantities. Methods for inducing purgation of the colon and for cleansing the colon are also disclosed.
    Type: Grant
    Filed: June 14, 2021
    Date of Patent: July 12, 2022
    Assignee: Braintree Laboratories, Inc.
    Inventors: Mark vB Cleveland, Edmund V. Dennett, Jr., Russell W Pelham
  • Publication number: 20210299050
    Abstract: Disclosed herein are solid oral dosage formulations comprising sodium sulfate, magnesium sulfate, and potassium chloride for inducing purgation of the colon of a subject. Furthermore, the disclosed compositions and formulations are useful to cleanse the colon when administered in sufficient quantities. Methods for inducing purgation of the colon and for cleansing the colon are also disclosed.
    Type: Application
    Filed: June 14, 2021
    Publication date: September 30, 2021
    Applicant: Braintree Laboratories, Inc.
    Inventors: Mark vB Cleveland, Edmund V. Dennett, JR., Russell W. Pelham
  • Publication number: 20210290546
    Abstract: Disclosed herein are solid oral dosage formulations comprising sodium sulfate, magnesium sulfate, and potassium chloride for inducing purgation of the colon of a subject. Furthermore, the disclosed compositions and formulations are useful to cleanse the colon when administered in sufficient quantities. Methods for inducing purgation of the colon and for cleansing the colon are also disclosed.
    Type: Application
    Filed: June 7, 2021
    Publication date: September 23, 2021
    Applicant: Braintree Laboratories, Inc.
    Inventors: Mark vB Cleveland, Edmund V. Dennett, JR., Russell W. Pelham
  • Patent number: 11033498
    Abstract: Disclosed herein are solid oral dosage formulations comprising sodium sulfate, magnesium sulfate, and potassium chloride for inducing purgation of the colon of a subject. Furthermore, the disclosed compositions and formulations are useful to cleanse the colon when administered in sufficient quantities. Methods for inducing purgation of the colon and for cleansing the colon are also disclosed.
    Type: Grant
    Filed: December 3, 2018
    Date of Patent: June 15, 2021
    Assignee: Braintree Laboratories, Inc.
    Inventors: Mark vB. Cleveland, Edmund V. Dennett, Jr., Russell W. Pelham
  • Publication number: 20200352855
    Abstract: Disclosed herein are compositions comprising a mixture of salts that induce purgation of the colon and are useful to cleanse the colon. Furthermore, the disclosed compositions can comprise a flavoring agent and polyethylene glycol. The disclosed compositions are superior to prior art compositions in that the disclosed compositions allow for higher tolerability, lower volumes, and improved patient compliance. In some embodiments, the composition comprises non-fermentable carbohydrates. Methods for inducing purgation of the colon and for cleansing the colon are also disclosed.
    Type: Application
    Filed: May 9, 2019
    Publication date: November 12, 2020
    Applicant: Sebela Pharmaceuticals, Inc.
    Inventors: Mark Cleveland, Edmund V. Dennett, JR., Russell W. Pelham, Matthew Walker
  • Patent number: 10806743
    Abstract: Disclosed herein are formulations comprising lactitol for the treatment of chronic idiopathic constipation. As disclosed herein, the formulations are administered after or during a meal to improve the pharmacokinetics of the formulation. In particular, administration of the formulation after or during a meal decreases the absorption of lactitol and reduces the AUC.
    Type: Grant
    Filed: May 12, 2017
    Date of Patent: October 20, 2020
    Inventors: Mark vB Cleveland, Robert M Raleigh, Russell W Pelham
  • Publication number: 20190099375
    Abstract: Disclosed herein are solid oral dosage formulations comprising sodium sulfate, magnesium sulfate, and potassium chloride for inducing purgation of the colon of a subject. Furthermore, the disclosed compositions and formulations are useful to cleanse the colon when administered in sufficient quantities. Methods for inducing purgation of the colon and for cleansing the colon are also disclosed.
    Type: Application
    Filed: December 3, 2018
    Publication date: April 4, 2019
    Applicant: Braintree Laboratories, Inc.
    Inventors: Mark vB. Cleveland, Edmund V. Dennett, JR., Russell W. Pelham
  • Patent number: 10143656
    Abstract: Disclosed herein are solid oral dosage formulations comprising sodium sulfate, magnesium sulfate, and potassium chloride for inducing purgation of the colon of a subject. Furthermore, the disclosed compositions and formulations are useful to cleanse the colon when administered in sufficient quantities. Methods for inducing purgation of the colon and for cleansing the colon are also disclosed.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: December 4, 2018
    Inventors: Mark vB. Cleveland, Edmund V. Dennett, Jr., Russell W. Pelham
  • Publication number: 20120265011
    Abstract: The present disclosure provides a bowel preparation procedure for capsule endoscopy for the examination of GI tract. The present disclosure also provides an improved method of examining the interior of the GI tract and of identifying the type, location, and cause of a GI pathology using an oral sulfate composition that enhances capsule endoscopic procedures, including transit time, and which purges and cleanses the GI tract of the patient.
    Type: Application
    Filed: April 16, 2012
    Publication date: October 18, 2012
    Applicant: BRAINTREE LABORATORIES, INC.
    Inventor: Russell W. Pelham
  • Patent number: 7291324
    Abstract: Stimulant laxative in combination with an osmotic laxative produces safe and effective bowel and colon cleansing with a reduced volume of liquid input. Administering to a patient an oral stimulant laxative, such as bisacodyl, followed, after a biologically determined interval, by a reduced volume of a PEG in water solution cleanses the bowels and colon in preparation for diagnostic colonoscopy, without the profuse uncontrollable diarrhea that typically follows either ingestion of large volume isotonic ravages, or smaller volume hypertonic lavages.
    Type: Grant
    Filed: October 22, 2002
    Date of Patent: November 6, 2007
    Assignee: Braintree Laboratories Inc.
    Inventors: Edmund V. Dennett, Jr., Robert M. Raleigh, Jr., Mark V B. Cleveland, Russell W. Pelham
  • Publication number: 20040191213
    Abstract: Stimulant laxative in combination with an osmotic laxative produces safe and effective bowel and colon cleansing with a reduced volume of liquid input. Administering to a patient an oral stimulant laxative, such as bisacodyl, followed, after a biologically determined interval, by a reduced volume of a PEG in water solution cleanses the bowels and colon in preparation for diagnostic colonoscopy, without the profuse uncontrollable diarrhea that typically follows either ingestion of large volume isotonic ravages, or smaller volume hypertonic ravages.
    Type: Application
    Filed: October 22, 2002
    Publication date: September 30, 2004
    Inventors: Russell W. Pelham, Vivian Caballero, Edmund V. Dennett, Bruce H. Aronson, Robert M. Raleigh, Mark vB. Cleveland
  • Patent number: 6645481
    Abstract: Overnight relief of constipation symptoms is achieved, and control of bowel function is enhanced by oral administration of an effective or sufficient amount of a composition comprising polyethylene glycol (PEG), preferably dispersed and or dissolved in an aqueous medium. The PEG compositions used for the present invention are preferably substantially free of ancillary electrolytes.
    Type: Grant
    Filed: September 28, 2000
    Date of Patent: November 11, 2003
    Assignee: Braintree Laboratories, Inc.
    Inventors: Mark vB. Cleveland, Russell W. Pelham
  • Patent number: 6048901
    Abstract: Intestinal gas, cramping and/or anorectal irritation are treated by oral administration of an effective or sufficient amount of a composition comprising polyethylene glycol, preferably dispersed and/or dissolved in an aqueous medium. The PEG compositions used for the present invention are desirably substantially free of ancillary electrolytes.
    Type: Grant
    Filed: July 7, 1999
    Date of Patent: April 11, 2000
    Assignee: Braintree Laboratories, Inc.
    Inventors: Mark vB. Cleveland, Russell W. Pelham
  • Patent number: 4540410
    Abstract: A syringe containing a lyophilized mixture of an absorbable gelatin powder and aminocaproic acid is prepared by mixing the gelatin powder, aminocaproic acid and water to form a slurry, introducing an aliquot of the slurry into a syringe and freeze-drying the slurry in the syringe.
    Type: Grant
    Filed: November 16, 1982
    Date of Patent: September 10, 1985
    Assignee: Serono Pharmaceutical Partners
    Inventors: Grace Wood, Benjamin R. Duce, Russell W. Pelham, James Woiszwillo
  • Patent number: 4521407
    Abstract: The cellular immune system of a person having acquired immune deficiency syndrome is stimulated by administering an immunopotentiating effective amount of a calf thymus extract to such person, the extract showing, upon electrophoresis on polyacrylamide gel at pH 8.6 two main characteristic bands with an Rf of about 0.25 and 0.44.
    Type: Grant
    Filed: August 29, 1983
    Date of Patent: June 4, 1985
    Assignee: Serono Pharmaceutical Partners
    Inventors: Russell W. Pelham, Charlotte S. Redden, Aliza Eshkol, Gerald E. Stiles